04/24/2024
4:00 PM | Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
5:46 AM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
3:34 PM | Neumora Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/07/2024
6:08 AM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
3:20 PM | Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:21 PM | Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:13 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/16/2024
3:14 PM | Milligan Michael Lee (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:15 PM | Gosebruch Henry O (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
7:32 AM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2023
6:52 PM | Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
6:52 PM | ARCH Venture Fund VII, L.P. (Reporting)
ARCH Venture Fund VIII Overage, L.P. (Reporting)
ARCH Venture Fund X Overage, L.P. (Reporting)
ARCH Venture Fund X, L.P. (Reporting)
ARCH Venture Partners VII, L.P. (Reporting)
ARCH Venture Partners VII, LLC (Reporting)
ARCH Venture Partners VIII, LLC (Reporting)
ARCH Venture Partners X Overage, L.P. (Reporting)
ARCH Venture Partners X, L.P. (Reporting)
ARCH Venture Partners X, LLC (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
6:53 PM | ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Partners XII, L.P. (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
NELSEN ROBERT (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
5:15 PM | Duncan Jason (Reporting)
Neumora Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/12/2023
5:16 PM | Duncan Jason (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2023
3:21 PM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2023
5:54 PM | ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Partners XII, L.P. (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
NELSEN ROBERT (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2023
5:55 PM | Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
6:00 PM | ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Partners XII, L.P. (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
NELSEN ROBERT (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
6:01 PM | Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
5:59 PM | ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Partners XII, L.P. (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
NELSEN ROBERT (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
6:00 PM | Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/29/2023
5:53 PM | ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Partners XII, L.P. (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
NELSEN ROBERT (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/29/2023
5:55 PM | Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2023
7:18 PM | ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Partners XII, L.P. (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
NELSEN ROBERT (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2023
7:19 PM | Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2023
6:30 AM | AMGEN INC (Filed by)
Neumora Therapeutics (Subject)
| Form SC 13D | |
09/25/2023
8:37 PM | Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
8:38 PM | ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Partners XII, L.P. (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
NELSEN ROBERT (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/21/2023
7:30 AM | FMR LLC (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
5:15 AM | ARCH Venture Fund VII, L.P. (Reporting)
ARCH Venture Fund VIII Overage, L.P. (Reporting)
ARCH Venture Fund X Overage, L.P. (Reporting)
ARCH Venture Fund X, L.P. (Reporting)
ARCH Venture Partners VII, L.P. (Reporting)
ARCH Venture Partners VII, LLC (Reporting)
ARCH Venture Partners VIII, LLC (Reporting)
ARCH Venture Partners X Overage, L.P. (Reporting)
ARCH Venture Partners X, L.P. (Reporting)
ARCH Venture Partners X, LLC (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
5:16 AM | ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Partners X, LLC (Reporting)
ARCH Venture Partners XII, L.P. (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
NELSEN ROBERT (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
5:23 AM | Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
8:57 PM | Neumora Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/19/2023
8:47 PM | Gosebruch Henry O (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
6:52 PM | AMGEN INC (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
3:16 PM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2023
4:58 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
4:50 PM | Ho Maykin (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
4:51 PM | Fust Matthew K (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
4:52 PM | Halawa Alaa (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
It’s now possible to know the win rate of every trade… BEFORE you take it! (Ad) Would you like to know the historic win rate of every trade you take before you place it?
Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.
 >> You can grab your FREE, laminated copies right here << |
09/18/2023
4:54 PM | Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
4:56 PM | Neumora Therapeutics (Issuer)
Piacquad David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
3:12 PM | Neumora Therapeutics (Filer)
| Form 424B4 | |
09/18/2023
2:11 PM | Milligan Michael Lee (Reporting)
Neumora Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/17/2023
11:15 PM | Neumora Therapeutics (Filer)
| Form EFFECT | |
09/14/2023
8:22 PM | ARCH Venture Fund VII, L.P. (Reporting)
ARCH Venture Fund VIII Overage, L.P. (Reporting)
ARCH Venture Fund X Overage, L.P. (Reporting)
ARCH Venture Fund X, L.P. (Reporting)
ARCH Venture Partners VII, L.P. (Reporting)
ARCH Venture Partners VII, LLC (Reporting)
ARCH Venture Partners VIII, LLC (Reporting)
ARCH Venture Partners X Overage, L.P. (Reporting)
ARCH Venture Partners X, L.P. (Reporting)
ARCH Venture Partners X, LLC (Reporting)
Neumora Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/14/2023
8:29 PM | ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Partners X, LLC (Reporting)
ARCH Venture Partners XII, L.P. (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
NELSEN ROBERT (Reporting)
Neumora Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/14/2023
7:56 PM | Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/14/2023
5:52 PM | Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/14/2023
5:57 PM | Fust Matthew K (Reporting)
Neumora Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/14/2023
5:58 PM | Gosebruch Henry O (Reporting)
Neumora Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/14/2023
5:58 PM | AMGEN INC (Reporting)
Neumora Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/14/2023
5:59 PM | BERNS PAUL L (Reporting)
Neumora Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/14/2023
6:01 PM | FMR LLC (Reporting)
Neumora Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/14/2023
6:04 PM | Neumora Therapeutics (Issuer)
Suh Carol Y. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/14/2023
6:05 PM | Ho Maykin (Reporting)
Neumora Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/14/2023
6:06 PM | Neumora Therapeutics (Issuer)
Piacquad David (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/14/2023
6:06 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/14/2023
6:07 PM | Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/14/2023
6:08 PM | Halawa Alaa (Reporting)
Neumora Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/14/2023
1:03 PM | Neumora Therapeutics (Filer)
| Form CERT | |
09/13/2023
4:00 PM | Neumora Therapeutics (Filer)
| Form 8-A12B | |
09/11/2023
5:07 AM | Neumora Therapeutics (Filer)
| Form S-1/A | |
08/25/2023
4:03 PM | Neumora Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
